Navigation Links
DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks

The Drug Information Association (DIA) will host Safety is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies (December 10-12; Marina Square, Singapore).

Horsham, PA (Vocus) October 28, 2008 -- The field of medical product safety continues to grow in complexity, with both clinical trial safety and post-marketing pharmacovigilance becoming ever more critical in the development and marketed use of medical products. In response, the Drug Information Association (DIA) will host Safety is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies (December 10-12; Marina Square, Singapore).

This unique three-day conference will explore the latest safety-related regulatory initiatives, how to optimally utilize epidemiological, clinical pharmacological and other techniques, state-of-the-art risk management strategies, and how all of this can be pulled together to create a "system." Featured topics will include:

  • Latest international regulatory developments
  • Generating and assessing critical safety data during development
  • Compliance with clinical safety and post-marketing pharmacovigilance regulatory requirements in an evolving global environment
  • Relationship between compliance and quality in safety-related processes and procedures
  • Recent multinational initiatives under the International Conference on Harmonization (ICH) and Council for International Organizations of Medical Sciences (CIOMS)
  • New approaches in risk management, risk communication, labeling, and packaging to optimize medical product benefit while minimizing preventable harm
  • Patient safety
"Safety professionals from countries and regions that do not participate in ICH will learn about the latest pharmacovigilance regulatory advances, how to optimize epidemiological and clinical pharmacological techniques in both clinical safety and post-marketing, and state-of-the-art risk management strategies," says Program Chair Stephen A. Goldman, MD, FAPM, DFAPA, Managing Member, Stephen A. Goldman Consulting Services, LLC. "In addition, there will be updates on regulatory frameworks for pharmacovigilance in the US, EU, Japan, Australia, New Zealand, Singapore, Thailand, India and China in an effort to foster greater cooperation and collaboration for global patient safety."

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA (USA), and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit or call 215-442-6100.

Contact: Joe Krasowski
Joe.Krasowski @


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008
2. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
3. Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
4. First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009
5. CHADD to Host International Conference on AD/HD in Anaheim, CA; Olympian Bruce Jenner to Keynote
6. ResMed to Webcast First Quarter 2009 Earnings Conference Call
7. Endocare to Present at Oppenheimer 19th Annual Healthcare Conference
8. U.S. Preventive Medicine(R) to Preview The Prevention Plan(TM) at National Conference for Health Care Technology Innovators
9. Weight Watchers Announces Third Quarter 2008 Earnings Conference Call
10. American Well Systems CEO Roy Schoenberg to Present Live Public Demo of First Online Care Service at Health 2.0 Conference
11. AMN Healthcare Services to Present at the BIOCOM Investor Conference
Post Your Comments:
Related Image:
DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks
(Date:11/27/2015)... Denver, CO (PRWEB) , ... November 27, 2015 , ... ... U.S. cities are not changing the way that they are handling security in light ... increasing police and security presence in an attempt to stop an attack from reaching ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse and ... findings on the website. Click here to read the details now. ... were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology: